Clin Vaccine Immunol 2012,19(10):1609–1617.PubMedCentralPubMedCrossRef 23. Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, A-1210477 mw Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme
J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, et al.: Predicted strain coverage of meningococcal multicomponent vaccine in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 2013,13(5):416–425.PubMedCrossRef 24. Bettinger JA, Scheifele VX-689 DW, Halperin SA, Vaudry W, Fidlow J, Borrow R, Medini D, Tsang R: Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB). Vaccine 2013. doi:10.1016/j.vaccine.2013.03.063 25. ECDC Surveillance Report: Surveillance of Bacterial invasive Diseases in Europe; 2008/2009. http://www.ecdc.europa.eu/en/publications/Publications/1107_SUR_IBD_2008-09.pdf 26. Russell JE, Jolley KA, Feavers IM, Maiden MC, Suker J: PorA variable regions of Neisseria meningitidis . Emerg Infect Dis 2004,10(4):674–678.PubMedCentralPubMedCrossRef 27. Clarke SC, Diggle MA, Mölling P, Unemo M, Olcén P: Analysis of PorA variable region 3 in meningococci: implications for vaccine policy? Vaccine 2003,21(19–20):2468–2473.PubMedCrossRef 28. Mölling P,
Unemo M, Bäckman A, Olcén P: Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic
cases. APMIS 2000,108(7–8):509–516.PubMedCrossRef CA-4948 research buy 29. Suker J, Feavers IM, Achtman M, Morelli G, Wang JF, Maiden Sitaxentan MC: The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 1994,12(2):253–265.PubMedCrossRef 30. Comanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, Capecchi B, Ciucchi L, Rappuoli R, Pizza M: NadA diversity and carriage in Neisseria meningitidis . Infect Immun 2004, 72:4217–4223.PubMedCentralPubMedCrossRef 31. Jacobsson S, Thulin S, Mölling P, Unemo M, Comanducci M, Rappuoli R, Olcén P: Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine 2006, 24:2161–2168.PubMedCrossRef 32. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R: Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol 2010, 17:919–929.PubMedCentralPubMedCrossRef 33. Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, Comanducci M: Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.